Left ventricular enlargement in coxsackievirus-B3 induced chronic myocarditis - ongoing inflammation and an imbalance of the matrix degrading system

European Journal of Pharmacology

Volumn 630, Issue 1-3, 2010, Pages 145-151

  Rutschow, Susanne ^a   Leschka, Sebastian ^b   Westermann, Dirk ^a   Puhl, Kerstin ^a   Weitz, Anneke ^a   Ladyszenskij, Leonid ^a   Jaeger, Sebastian ^a   Zeichhardt, Heinz ^a   Noutsias, Michel ^a   Schultheiss, Heinz Peter ^a   Tschope, Carsten ^a   Pauschinger, Matthias ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c KLINIKUM NÜRNBERG   (Germany)

Author keywords

DCM; Inflammation; Matrix; MMP; Myocarditis

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; GAMMA INTERFERON; GELATINASE A; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; NEUTROPHIL COLLAGENASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; COXSACKIE VIRUS B3; DIASTOLIC DYSFUNCTION; DOWN REGULATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VIRUS MYOCARDITIS; ZYMOGRAPHY;

ANIMALS; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; HYPERTROPHY, LEFT VENTRICULAR; INFLAMMATION; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED STRAINS; MYOCARDITIS; SPECIFIC PATHOGEN-FREE ORGANISMS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 77649179112     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.12.019     Document Type: Article

References (32)

1. Arnold G., Kaiser C., Fischer R. Myofibrillar degeneration - a common type of myocardial lesion and its selective identification by a modified luxol fast blue stain. Pathol. Res. Pract. 1985, 180:405-415.
2. Bouluyt M.C., O'Neil L., Mededith A.L. Alteration in cardiac gene expression during the transition from stable hypertrophy to heart failure: Marked upregulation of genes encoding extracellular components. Circ. Res. 1994, 75:25-32.
3. Bradham W.S., Moe G., Wendt K.A. TNF-α. Am. J. Physiol. Heart Circ. Physiol. 2002, 282:H1288-H1295.
4. Cheung C., Luo H., Yanagawa B. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in coxsackievirus-induced myocarditis. Cardiovasc. Pathol. 2006, 15:63-74.
5. Creemers E., Cleutjens J., Smits J. Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. Am. J. Pathol. 2000, 156:1865-1873.
6. D'Armiento J. Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction. Trends Cardiovasc. Med. 2002, 12:97-101.
7. Fairweather D., Kaya Z., Shellam G.R. From infection to autoimmunity. J. Autoimmun. 2001, 16:175-186.
8. Feldman A.M., McNamara D. Myocarditis. N. Engl. J. Med. 2000, 9(343):1388-1398.
9. Heymans S., Pauschinger M., Palma A. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis. Circulation 2006, 114:565-573.
10. Kawai C. From myocarditis to cardiomyopathy: Mechanisms of inflammation and cell death. Learning from the past to the future. Circulation 1999, 96:3549-3554.
11. Klingel K., Hohenadl C., Canu A. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:314-318.
12. Kuhl U., Pauschinger M., Bock T. Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 2003, 108:945-950.
13. Kuhl U., Pauschinger M., Noutsias M. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation 2005, 111:887-893.
14. Li J., Schwimmbeck P.L., Tschope C. Collagen degradation in a murine myocarditis model: relevance of matrix metalloproteinase in association with inflammatory induction. Cardiovasc. Res. 2002, 56:235-247.
15. Li J., Leschka S., Rutschow S. Immunomodulation by interleukin-4 suppresses matrix metalloproteinases and improves cardiac function in murine myocarditis. Eur. J. Pharmacol. 2007, 554:60-68.
16. Matsumori A. Molecular and immune mechanisms in the pathogenesis of cardiomyopathy: role of viruses, cytokines and nitric oxide. Jpn. Circ. J. 1997, 61:275-291.
17. Mauviel A. Cytokine regulation of metalloproteinase gene expression. J. Cell. Biochem. 1993, 53:288-295.
18. Noutsias M., Seeberg B., Schultheiss H.P., Kuhl U. Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy. Circulation 1999, 99:2124-2131.
19. Noutsias M., Pauschinger M., Ostermann K. Digital image analysis system for the quantification of infiltrates and cell adhesion molecules in inflammatory cardiomyopathy. Med. Sci. Monit. 2002, 8:MT59-MT71.
20. Noutsias M., Hohmann C., Pauschinger M. sICAM-1 correlates with myocardial ICAM-1 expression in dilated cardiomyopathy. Int. J. Cardiol. 2003, 91:153-161.
21. Pauschinger M., Doerner A., Kuehl U. Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation 1999, 99:889-895.
22. Pauschinger M., Knopf D., Petschauer S. Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Circulation 1999, 99:2750-2756.
23. Rose N.R., Hill S.L. The pathogenesis of postinfectious myocarditis. Clin. Immunol. Immunopathol. 1996, 80:S92-S99.
24. Rutschow S., Li J., Schultheiss H.P., Pauschinger M. Myocardial proteases and matrix remodeling in inflammatory heart disease. Cardiovasc. Res. 2006, 69:646-656.
25. Seko Y., Shinkai Y., Kawasaki A. Expression of perforin in infiltrating cells in murine hearts with acute myocarditis caused by coxsackievirus B3. Circulation 1991, 84:788-795.
26. Shioi T., Matsumori A., Sasayama S. Persistent expression of cytokine in the chronic stage of viral myocarditis in mice. Circulation 1996, 94:2930-2937.
27. Siwik D.A., Chang D.L., Colucci W.S. Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metallopro-teinase activity in cardiac fibroblasts in vitro. Circ. Res. 2000, 86:1259-1265.
28. Thomas C.V., Coker M.L., Zellner J.L. Increased matrix metallo-proteinase activity and selective upregulation in LV myocardium from patients with endstage dilated cardiomyopathy. Circulation 1998, 97:1708-1715.
29. Tschope C., Westermann D., Steendijk P. Hemodynamic characterization of left ventricular function in experimental coxsackieviral myocarditis: effects of carvedilol and metoprolol. Eur. J. Pharmacol. 2004, 491:173-179.
30. Why H.J., Meany B.T., Richardson P.J. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 1994, 89:2582-2589.
31. Wilson F.M., Miranda Q.R., Chason J.L. Residual pathologic changes following murine coxsackie A and B myocarditis. Am. J. Pathol. 1969, 55:253-265.
32. Woodiwiss A.J., Tsotetsi O.J., Sprott S. Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction. Circulation 2001, 103:155-160.